New Ray Medicine International Holding Limited (HKG:2908)

HKG:2908 Revenue

In the year 2024, New Ray Medicine International Holding had annual revenue of 93.95M HKD with 87.31% growth. New Ray Medicine International Holding had revenue of 77.23M in the half year ending December 31, 2024, with 153.39% growth.

• Revenue: 93.95M
• Revenue Growth: +87.31%
• P/S Ratio: 0.71
• Revenue / Employee: 3.24M
• Employees: 29
• Market Cap: 66.87M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	93.95M	43.79M	87.31%
Dec 31, 2023	50.15M	-39.62M	-44.13%
Dec 31, 2022	89.77M	-245.61M	-73.23%
Dec 31, 2021	335.38M	202.17M	151.76%
Dec 31, 2020	133.21M	14.58M	12.29%